The FDA received 4 complaints of EpiPen failure in 2012. There have been 228 complaints and seven deaths this year.


The U.S. Food and Drug Administration has received 228 reports of EpiPen or EpiPen Jr. failures this year, resulting in seven deaths and 35 hospitalizations, Bloomberg News reports. The data, collected through mid-September, dwarfs that of years past: The FDA received only four reports of EpiPen and EpiPen Jr. failures in 2012 and just 12 in 2013, but there has been a 400 percent increase in failures since 2014, when the FDA received 67 complaints.
EpiPen products are sold by Mylan NV and made by Pfizer Inc.'s Meridian Medical Technologies. Pfizer has previously claimed that because "non-medically trained individuals" like parents or teachers are frequently administering EpiPens, consumer complaints about the use of their product were not unusual. The FDA also noted in a statement to Bloomberg that product complaints do not necessarily mean that the product itself was to blame if it did not work properly.
In September, however, the FDA sent a warning letter to Meridian Medical Technologies reporting that epinephrine — the hormone dispensed by EpiPens, which treats life-threatening allergic reactions — had in fact leaked out of certain pens and that in some cases, the devices' auto-injectors had failed to work. One woman told Bloomberg that in 2014, she had to take her son to the hospital after she was unsure if her EpiPen's auto-injector had worked properly.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Bloomberg also noted that these complaints may not paint a complete picture of the problem, given many people do not know that they can send complaints to the FDA. Mylan NV has also recently come under fire for significantly raising the price of the life-saving product.
It is estimated that nearly 4 million EpiPens were prescribed last year. Read more on the FDA's findings at Bloomberg.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Kelly O'Meara Morales is a staff writer at The Week. He graduated from Sarah Lawrence College and studied Middle Eastern history and nonfiction writing amongst other esoteric subjects. When not compulsively checking Twitter, he writes and records music, subsists on tacos, and watches basketball.
-
August 3 editorial cartoons
Cartoons Sunday’s political cartoons include a human data center, Donald Trump's enterprising spirit, and more
-
5 darkly funny cartoons about Israel blocking aid to Gaza
Cartoons Artists take on forcing famine, avoiding aid, and more
-
The easy elegance of Cap Ferret
The Week Recommends 'Elemental and otherworldly' destination is loved for its natural beauty
-
Samsung to make Tesla chips in $16.5B deal
Speed Read Tesla has signed a deal to get its next-generation chips from Samsung
-
FCC greenlights $8B Paramount-Skydance merger
Speed Read The Federal Communications Commission will allow Paramount to merge with the Hollywood studio Skydance
-
Tesla reports plummeting profits
Speed Read The company may soon face more problems with the expiration of federal electric vehicle tax credits
-
Dollar faces historic slump as stocks hit new high
Speed Read While stocks have recovered post-Trump tariffs, the dollar has weakened more than 10% this year
-
Economists fear US inflation data less reliable
speed read The Labor Department is collecting less data for its consumer price index due to staffing shortages
-
Crypto firm Coinbase hacked, faces SEC scrutiny
Speed Read The Securities and Exchange Commission has also been investigating whether Coinbase misstated its user numbers in past disclosures
-
Starbucks baristas strike over dress code
speed read The new uniform 'puts the burden on baristas' to buy new clothes, said a Starbucks Workers United union delegate
-
Warren Buffet announces surprise retirement
speed read At the annual meeting of Berkshire Hathaway, the billionaire investor named Vice Chairman Greg Abel his replacement